Outcome and toxicity of ifosfamide, carboplatin, and etoposide versus gemcitabine and vinorelbine regimen for pediatric patients with relapsed or refractory Hodgkin’s lymphoma

BACKGROUND: Pediatric classical Hodgkin lymphoma (CHL) is a curable disease; however, the optimal salvage regimen is unclear for relapsed/refractory (R/R) disease. This study aimed to compare response rates, toxicity, event-free survival (EFS), and overall survival (OS) of ifosfamide, carboplatin, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahdy, Ahmed, Hamoda, Asmaa, Zaher, Ahmed, Khorshed, Eman, Elwakeel, Madeha, Hassanein, Omneya, Sidhom, Iman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335766/
https://www.ncbi.nlm.nih.gov/pubmed/37441423
http://dx.doi.org/10.3389/fonc.2023.1153128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335766/
https://www.ncbi.nlm.nih.gov/pubmed/37441423
http://dx.doi.org/10.3389/fonc.2023.1153128

Ejemplares similares